Bruker Corporation
BRKR Healthcare Medical Devices
Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024.
- Revenue
- +1.57%
- EPS
- −75.4%
- Free cash flow
- +278.7%
- Total debt
- −14.7%
Quarter to September 2026, against a year earlier
Follow BRKR
Alert me
Bruker Corporation (BRKR) P/S ratio
As of 5 November 2026, Bruker Corporation (BRKR) trades at a P/S ratio of 2.5×. Over the past ten years it has ranged from 1.3× (September 2025) to 6.1× (September 2021); the current reading is higher than 31% of that period. That is in line with the Medical Devices industry median of 2.5× and below the Healthcare sector median of 3.5×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 2.1× | (19.79%) |
| FY2024 | 2.6× | (27.33%) |
| FY2023 | 3.6× | (11.96%) |
| FY2022 | 4.1× | (22.81%) |
| FY2021 | 5.3× | 25.76% |
| FY2020 | 4.2× | 9.46% |
| FY2019 | 3.8× | 55.59% |
| FY2018 | 2.5× | (20.63%) |
| FY2017 | 3.1× | 42.98% |
| FY2016 | 2.2× | (14.02%) |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Sep 2026 | 2.8× | 7.32% |
| Jun 2026 | 2.6× | 64.76% |
| Mar 2026 | 1.6× | (23.61%) |
| Dec 2025 | 2.1× | 45.10% |
| 43 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | 1.4× |
| BRKR Bruker Corporation | 2.5× |
| PODD Insulet Corporation compare | 3.4× |
| GMED Globus Medical, Inc. compare | 3.5× |
| BIO Bio-Rad Laboratories, Inc. compare | 3.8× |
| BIO.B Bio-Rad Laboratories, Inc. compare | 3.9× |
| PEN Penumbra, Inc. compare | 8.1× |
| TXG 10x Genomics compare | 12.4× |
| GKOS Glaukos Corporation compare | 18.8× |
| Medical Devices industry median | 2.5× |
| Healthcare sector median | 3.5× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on BRKR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement